Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Nov 2011

Buti Sebastiano, Donini Maddalena, Sergio Pietro, Garagnani Lorella, Schirosi Laura, Passalacqua Rodolfo, Rossi Giulio

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Imatinib Mesylate
Share to Neoplasm Metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Piperazines

Share to Proto-Oncogene Proteins c-kit

Share to Pyrimidines

Share to Thymoma

Share to Thymus Neoplasms

Source

Identifiers

PMID: 21969494
DOI: 10.1200/JCO.2011.36.6427

Genes

KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma.PMID 21969494Read ↗

A new KIT gene mutation in thymic cancer and a promising response to imatinib.Semantic proximity Read ↗

When a thymic carcinoma "becomes" a GIST.Semantic proximity Read ↗

Stabilization of disease after targeted therapy in a thymic carcinoma with KIT mutation detected by clinical next-generation sequencing.Semantic proximity Read ↗

Imatinib mesylate in thymic epithelial malignancies.Semantic proximity Read ↗

Imatinib in c-KIT-mutated metastatic solid tumors: A multicenter trial of Korean Cancer Study Group (UN18-05 Trial).Semantic proximity Read ↗

Impressive Response to Tyrosine Kinase Inhibitors in a Patient with Respiratory Failure for EGFR-Mutated Metastatic Lung Cancer.Semantic proximity Read ↗

Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas.Semantic proximity Read ↗

Do thymic malignancies respond to target therapies?Semantic proximity Read ↗

Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience.Semantic proximity Read ↗

Response to Imatinib in a Patient with Double-mutant KIT Metastatic Penile Melanoma.Semantic proximity Read ↗

Expression and mutational status of c-kit in thymic epithelial tumors.Semantic proximity Read ↗

Molecular aspects of thymic carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.